Protein NameCytochrome c, somatic
Gene[CYCS](/genes/cycs)
UniProt ID[P99999](https://www.uniprot.org/uniprot/P99999)
PDB ID1HRC, 3ZCF
Molecular Weight~11.7 kDa (104 amino acids)
Subcellular LocalizationMitochondrial intermembrane space
Protein FamilyCytochrome c family
CofactorHeme c (covalently bound)
Cytochrome c is a small, highly conserved heme protein that serves a dual role in cellular physiology: as an essential electron carrier in the mitochondrial electron transport chain (Complex III → Complex IV) and as a critical trigger of intrinsic apoptosis when released into the cytosol. In neurons, which are exquisitely sensitive to both energy failure and inappropriate cell death, cytochrome c sits at the nexus of mitochondrial bioenergetics and survival signaling. Its release from mitochondria is a pivotal, often irreversible, commitment step in neuronal death across Alzheimer's disease, Parkinson's disease, stroke, and traumatic brain injury.
Cytochrome c is a 104-amino-acid globular protein with a tightly packed alpha-helical fold surrounding a single heme c prosthetic group:
- Heme attachment: The iron-porphyrin ring is covalently linked via thioether bonds to Cys14 and Cys17 through a conserved CXXCH motif. His18 and Met80 serve as axial ligands to the central iron atom.
- Redox-active iron: Cycles between Fe²⁺ (reduced, ferrocytochrome c) and Fe³⁺ (oxidized, ferricytochrome c) during electron transfer, with a midpoint potential of +260 mV.
- Lysine-rich surface: A ring of positively charged lysine residues (Lys13, Lys72, Lys73, Lys79, Lys86, Lys87) mediates electrostatic interactions with the negatively charged surfaces of Complex III, Complex IV, and Apaf-1.
- Cardiolipin binding site: A hydrophobic patch and a secondary lipid-binding site anchor cytochrome c to the inner mitochondrial membrane via cardiolipin, a phospholipid critical for its retention in the intermembrane space.
- Structural compactness: The protein lacks significant disordered regions, contributing to its extreme stability (Tm > 80 °C) and evolutionary conservation (>95 % identity between human and horse sequences).
In its primary bioenergetic role, cytochrome c is a mobile electron shuttle in the mitochondrial intermembrane space:
- Accepts electrons from Complex III (cytochrome bc1): the Rieske iron-sulfur subunit reduces cytochrome c via the Q-cycle mechanism
- Delivers electrons to Complex IV (cytochrome c oxidase): binds to subunit II, transferring one electron at a time to the CuA center
- Rate-limiting step: The diffusion of cytochrome c between Complexes III and IV can become rate-limiting for oxidative phosphorylation under conditions of membrane crowding or cardiolipin depletion
In neurons, which derive ~95 % of ATP from oxidative phosphorylation, even modest reductions in cytochrome c availability or function impair synaptic transmission and axonal transport.
Upon mitochondrial outer membrane permeabilisation (MOMP), cytochrome c is released into the cytosol where it triggers the caspase activation cascade:
- MOMP trigger: Pro-apoptotic BCL-2 family members (BAX, BAK) oligomerise to form pores in the outer mitochondrial membrane
- Cardiolipin oxidation: ROS-mediated peroxidation of cardiolipin weakens cytochrome c tethering, facilitating release
- Apoptosome assembly: Cytosolic cytochrome c binds Apaf-1 in a dATP-dependent manner, triggering Apaf-1 oligomerisation into the heptameric apoptosome
- Caspase-9 activation: The apoptosome recruits and activates procaspase-9, which then cleaves and activates executioner caspases-3 and -7
- Point of no return: Once sufficient cytochrome c is released, the process is considered irreversible in most cell types, though neurons have evolved partial resistance through XIAP and other IAP proteins
¶ ROS Scavenging and Cardiolipin Peroxidase Activity
Beyond electron transfer and apoptosis, cytochrome c possesses intrinsic peroxidase activity when its Met80-Fe bond is disrupted:
- In complex with cardiolipin, cytochrome c gains peroxidase activity, selectively oxidising cardiolipin
- This creates a positive feedback loop: cardiolipin peroxidation → weakened cytochrome c binding → more cytochrome c release → more peroxidase activity
- Under physiological conditions, reduced cytochrome c scavenges superoxide (O₂⁻), acting as a mitochondrial antioxidant
Cytochrome c release is a well-documented feature of amyloid-beta (Aβ)-induced neuronal death:
- Aβ oligomers trigger mitochondrial membrane depolarisation and BAX translocation
- Cytochrome c is released from hippocampal and cortical neuron mitochondria in AD brain tissue (post-mortem studies show elevated cytosolic cytochrome c)
- Aβ directly interacts with mitochondrial membranes, disrupting the electron transport chain at the cytochrome c–Complex IV interface
- Caspase-3 activation downstream of cytochrome c release contributes to tau cleavage at Asp421, generating a pro-aggregation tau fragment that accelerates tangle formation
In PD, cytochrome c release is central to dopaminergic neuron vulnerability:
- Alpha-synuclein oligomers bind cardiolipin on the inner mitochondrial membrane, displacing cytochrome c and directly promoting its release
- Complex I inhibition (by MPTP/rotenone) increases ROS, oxidises cardiolipin, and triggers cytochrome c release → caspase-dependent death of substantia nigra neurons
- PINK1/Parkin pathway deficiency leads to accumulation of damaged mitochondria with impaired cytochrome c retention
- Post-mortem PD substantia nigra shows elevated cytosolic cytochrome c and activated caspase-9
¶ Stroke and Excitotoxicity
Ischaemia–reperfusion injury causes massive cytochrome c release due to calcium overload, ROS burst, and mitochondrial permeability transition pore (mPTP) opening:
- Glutamate excitotoxicity via NMDA receptors drives mitochondrial calcium uptake → mPTP opening → cytochrome c release
- The penumbral region shows a gradient of cytochrome c release correlating with distance from the ischaemic core
- Hypothermia neuroprotection partly works by preserving cytochrome c in the intermembrane space
Mechanical disruption of neuronal mitochondria in TBI causes immediate and delayed cytochrome c release, with CSF cytochrome c levels serving as a biomarker of injury severity.
- BCL-2 family modulators: Overexpression of BCL-XL prevents BAX pore formation and cytochrome c release in AD and PD models
- mPTP inhibitors: Cyclosporin A and its non-immunosuppressive analogue Debio 025 block mPTP-mediated cytochrome c release
- Caspase inhibitors: Z-VAD-FMK and minocycline (a broad caspase inhibitor) are neuroprotective downstream of cytochrome c release
- SS-31 (elamipretide): A mitochondria-targeted peptide that stabilises cardiolipin–cytochrome c interactions, preventing cytochrome c detachment and peroxidase activation; Phase II trials in mitochondrial myopathy and heart failure
- Cardiolipin-targeted antioxidants: MitoQ and other mitochondria-targeted compounds reduce cardiolipin peroxidation
Cytochrome c levels in cerebrospinal fluid and plasma are elevated in stroke, TBI, and fulminant hepatic failure, and are being evaluated as a rapid biomarker for mitochondrial injury severity in neurological emergencies.